<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26589473</identifier>
<setSpec>1695-9531</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Hernández Merino, A</dc:author>
<dc:author>Ruiz-Contreras, J</dc:author>
<dc:author>Corretger Rauet, J M</dc:author>
<dc:author>Ortigosa del Castillo, L</dc:author>
<dc:author>Cilleruelo Ortega, M J</dc:author>
<dc:author>Arístegui Fernández, J</dc:author>
<dc:author>García Sánchez, N</dc:author>
<dc:author>Merino Moína, M</dc:author>
<dc:author>Moreno-Pérez, D</dc:author>
<dc:author>Álvarez García, F J</dc:author>
<dc:author>Hernández-Sampelayo Matos, T</dc:author>
<dc:description xml:lang="en">The Advisory Committee on Vaccines of the Spanish Association of Paediatrics (CAV-AEP) annually publishes the immunisation schedule which, in our opinion, estimates optimal for children resident in Spain, considering available evidence on current vaccines. We acknowledge the effort of the Ministry of Health during the last year in order to optimize the funded unified Spanish vaccination schedule, with the recent inclusion of pneumococcal and varicella vaccination in early infancy. Regarding the funded vaccines included in the official unified immunization schedule, taking into account available data, CAV-AEP recommends 2+1 strategy (2, 4 and 12 months) with hexavalent (DTPa-IPV-Hib-HB) vaccines and 13-valent pneumococcal conjugate vaccine. Administration of Tdap and poliomyelitis booster dose at the age of 6 is recommended, as well as Tdap vaccine for adolescents and pregnant women, between 27-36 weeks gestation. The two-dose scheme should be used for MMR (12 months and 2-4 years) and varicella (15 months and 2-4 years). Coverage of human papillomavirus vaccination in girls aged 11-12 with a two dose scheme (0, 6 months) should be improved. Information for male adolescents about potential beneficial effects of this immunisation should be provided as well. Regarding recommended unfunded immunisations, CAV-AEP recommends the administration of meningococcal B vaccine, due to the current availability in Spanish communitary pharmacies, with a 3+1 scheme (3, 5, 7 and 13-15 months). CAV-AEP requests the incorporation of this vaccine in the funded unified schedule. Vaccination against rotavirus is recommended in all infants. Annual influenza immunisation and vaccination against hepatitis A are indicated in population groups considered at risk.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Vaccine preventable diseases</dc:subject>
<dc:subject>Calendario de vacunación</dc:subject>
<dc:subject>Niños</dc:subject>
<dc:subject>Vacunas</dc:subject>
<dc:subject>Children</dc:subject>
<dc:subject>Vaccines</dc:subject>
<dc:subject>Immunisation schedule</dc:subject>
<dc:subject>Enfermedades inmunoprevenibles</dc:subject>
<dc:date>2016 Jan </dc:date>
<dc:title xml:lang="es">Calendario de vacunaciones de la Asociación Española de Pediatría (CAV-AEP): recomendaciones 2016.</dc:title>
<dc:title xml:lang="en">[Immunisation schedule of the Spanish Association of Paediatrics: 2016 recommendations].</dc:title>
<dc:publisher>Anales de pediatria (Barcelona, Spain : 2003)</dc:publisher>
</metadata>
</record>
</pubmed-document>
